Salarius Pharmaceuticals (SLRX) announced that in connection with its recent combination with Decoy Therapeutics (DCOY), the Company intends to ...

Preceding the University of Miami licensing agreement, Biocerta entered into a comprehensive development and commercialization agreement with Acumen Partners, a healthcare investment and advisory firm ...

Valink Therapeutics ("Valink"), a private biotechnology company developing next-generation therapeutics with a focus on bispecific antibody-drug conjugates (bsADCs) and complementary modalities, and ...

OpenAI, Anthropic and Google have been on the prowl for specialized data to train their AI models, discussing deals with ...

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company advancing regenerative medicine solutions, today announced the successful completion of patient ...

Manufacture of multiple Dyadic-origin products by Fermbox Bio , enabling efficient production and market expansion of sustainable, animal-free proteins and enzymes. Dual-Sourcing flexibility, allowing ...

Cellarim Labs is also building an AI driven biofoundry that enables partner brands to submit target molecules for design, testing, and production, with the aim of redu ...

UC San Diego researchers have engineered bacteria to produce octopus pigment, potentially revolutionizing cosmetics, textiles ...

Ladenburg Thalmann & Co. Inc. is acting as the exclusive placement agent for the offering.

Shares of Aldeyra Therapeutics were sharply lower in premarket trading Tuesday after the biotechnology company said the U.S. Food and Drug Administration's review of its proposed reproxalap treatment ...

The European Research Council (ERC) has announced the results of its 2025 Consolidator Grant call, selecting two projects led ...

Dyadic Applied BioSolutions (“Dyadic”) (NASDAQ: DYAI), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes across life science, food & nutrition, and ...